Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01132755 · ClinicalTrials.gov registry record · Phase 2

Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage

A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 2
Development phase
112
Enrollment target

NCT01132755: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01132755 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01132755, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
112 participants
Enrollment target

Study Summary

This study is being done to develop a new method that can rapidly stage patients with gastric and pancreas cancer. Staging means finding out what is the extent of the cancer in a patient's body. Currently before patients have the surgery to remove their cancer, a surgical exam is done in the operating room to see if their cancer has spread. A thin tube-like instrument with lens and a light is placed into the abdomen. This is done by making small cuts into the body. This exam is called a diagnostic laparoscopy. If cancer spread is not seen, fluid is put into the abdomen and then taken out. This is called "lavage" or washing. The fluid is then looked at in a laboratory. If the fluid contains cancer cells surgery is often delayed. The investigators are testing a new method to put the fluid into the abdomen. It is called percutaneous lavage. Percutaneous means "through the skin". A needle is put through the skin into the abdomen. Tubing is then placed over the needle so that fluid can be put into the abdomen and then taken out. The fluid is then looked at in a laboratory. The investigators want to see if the two methods are equal because if they are equal, in the future, patients may be able to have this procedure done outside of the operating room.

Interventions

  • PROCEDURE Diagnostic peritoneal lavage

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2010-05
Est. Completion 2017-08-16
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01132755

The ClinicalTrials.gov registry entry for NCT01132755 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diagnostic peritoneal lavage is the first listed.

NCT01132755 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01132755 about?

NCT01132755 is a clinical study titled "Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage". This study is being done to develop a new method that can rapidly stage patients with gastric and pancreas cancer. Staging means finding out what is the extent of the cancer in a patient's body. Currently before patients have the surgery to remove their cancer, a surgical exam is done in the operat...

What is the current status of trial NCT01132755?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2010-05. Estimated completion is 2017-08-16.

What interventions are being tested in trial NCT01132755?

The interventions under investigation include: Diagnostic peritoneal lavage (PROCEDURE).

Who is sponsoring clinical trial NCT01132755?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.